A Biotech CFO Repeats at $10.32, But RSI Hit 82
Andrew Booth runs the money at AbCellera, and he just put $383,904 into his own name at $10.32. Second insider buy in a month here, and Booth's a repeat buyer, which is the kind of cluster that usually gets my attention. Problem is the tape is stretched. RSI at 82.9 and money flow near 95 means everyone's already piled in, and buying up here means paying well above where Booth got filled. Insiders on this name win about six times out of ten and the 90-day returns have been strong, so this one's worth watching for a pullback toward his price rather than chasing the top.
The Filing
| Ticker | ABCL |
| Company | AbCellera Biologics Inc. |
| Insider | Andrew Booth, Chief Financial Officer |
| Buy amount | $383,904 |
| Filing date | August 14, 2026 |
| Conviction | Interesting · 58/100 |
| Setup type | Overbought Entry |
Ultimate members received this analysis in real time.